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Here, we highlight the potential translational benefits of delivering
FLASH radiotherapy using ultra-high dose rates (>100 Gy·s−1). Com-
pared with conventional dose-rate (CONV; 0.07–0.1 Gy·s−1) modali-
ties, we showed that FLASH did not cause radiation-induced deficits
in learning and memory in mice. Moreover, 6 months after expo-
sure, CONV caused permanent alterations in neurocognitive end
points, whereas FLASH did not induce behaviors characteristic of
anxiety and depression and did not impair extinction memory.
Mechanistic investigations showed that increasing the oxygen ten-
sion in the brain through carbogen breathing reversed the neuro-
protective effects of FLASH, while radiochemical studies confirmed
that FLASH produced lower levels of the toxic reactive oxygen spe-
cies hydrogen peroxide. In addition, FLASH did not induce neuro-
inflammation, a process described as oxidative stress-dependent,
and was also associated with a marked preservation of neuronal
morphology and dendritic spine density. The remarkable normal
tissue sparing afforded by FLASH may someday provide hereto-
fore unrealized opportunities for dose escalation to the tumor
bed, capabilities that promise to hasten the translation of this
groundbreaking irradiation modality into clinical practice.
ultra-high dose-rate irradiation | cognitive dysfunction | neuronal
morphology | neuroinflammation | reactive oxygen species
Radiation therapy (RT) remains an essential part of cancertreatment, and, today, the benefit of RT would increase dra-
matically if normal tissues surrounding the tumor could tolerate
higher doses of radiation (1–3). In the last decade, major advances
in high-precision treatment delivery and multimodal imaging have
improved tolerance to RT (4), but the selective protection of
normal tissue remains a significant clinical challenge and the
radiation-induced toxicities still adversely impact the patient’s
quality of life. This latter fact largely remains an unmet medical
need, and points to the urgency of developing improved RT mo-
dalities for combating those cancers refractory to treatment.
This issue is especially critical for those afflicted with brain
tumors, including glioblastoma multiforme (GBM), for which
standard treatment consists of surgical resection followed by RT
and concomitant chemotherapy (temozolomide). Typical radio-
therapeutic protocols for GBM induce neurocognitive compli-
cations, including impairments in learning and memory, attention,
and executive function and a variety of mood disorders (5–8). A
breadth of past work from our laboratories has linked adverse
neurocognitive outcomes following cranial irradiation to a range
of neuropathologies, including reductions in dendritic complexity
and spine density (9–12), reductions in microvascular density (13–
15), reduced myelination and synapse density, and increased
neuroinflammation (16, 17). These changes are persistent and
problematic in the conventionally irradiated brain and have
prompted efforts to more fully develop a truly innovative approach
to RT, where we have conceptualized and implemented a modality
of irradiation named FLASH radiotherapy (FLASH-RT) (18, 19).
Cognitive sparing was demonstrated when single doses of 10 Gy
were delivered at dose rates exceeding 100 Gy·s−1, with an ap-
parent threshold when dose rates fell below ∼30 Gy·s−1 (19).
While existing data indicate that FLASH-RT does not induce
neurocognitive impairment, comprehensive studies investigating
the mechanistic basis of the beneficial “FLASH effect” remained
to be undertaken.
Using healthy mouse models, we undertook direct compari-
sons between FLASH-RT and conventional dose-rate (CONV)
irradiation modalities that were facilitated throughout this study
by performing all experiments under isodose conditions. We
found that FLASH-irradiated mice did not exhibit neurocognitive
decline, and were spared a host of associated pathologies. Further
mechanistic experimentation explored the physicochemical basis
of the FLASH effect (20) through the modulation of oxygen
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concentration in the brain. We found that by doubling the oxy-
gen content through carbogen breathing, the neurocognitive
benefits of FLASH-RT found after normoxic exposure condi-
tions were eliminated. These data point to the critical impor-
tance of local oxygen levels, and suggest a rapid radiation-
induced depletion of O2 that elicits tissue hypoxia, thereby
pointing to a fundamental and initial physicochemical mecha-
nism for the FLASH effect. In addition, we identified subsequent
mechanisms of neuroprotection in the FLASH-irradiated brain,
thereby promoting the translational potential of this promising
modality for minimizing normal tissue toxicity following the
treatment of brain cancer.
Results
FLASH-RT Does Not Induce Cognitive Dysfunction. We investigated
the impact of FLASH-RT on short-term and longer term neu-
rocognitive sequelae typically found after CONV treatments.
Cognitive studies were conducted in tumor-free animals so that
behavioral data could be collected and evaluated under carefully
controlled conditions and in the absence of confounding disease
that would otherwise cause premature death of the animal be-
fore long-term analyses.
Thus, studies were initiated 1 mo after irradiation on animals
subjected to a series of spontaneous exploration tasks known to
interrogate hippocampal and frontal cortical learning and
memory. Animals exposed to the cranial 10-Gy FLASH irradi-
ation and subjected to the novel object recognition (NOR) task
(Fig. 1A) were statistically indistinguishable from controls,
whereas the 10-Gy CONV–irradiated cohort exhibited a re-
duction in their discrimination index (DI). Significantly, no loss
of performance on this task was shown up to 12 Gy delivered as
FLASH-RT, but the FLASH effect was finally lost in cohorts
exposed to 14 Gy, where animals exhibited an impaired NOR
performance (reduced DI) comparable to the CONV cohort (SI
Appendix, Fig. S1). Following NOR testing, mice were habitu-
ated and tested on the object in place (OIP) and temporal order
(TO) tasks (Fig. 1 B and C). Similarly, the two tests showed that
the 10-Gy FLASH cohort was statistically indistinguishable from
controls, whereas the CONV cohort showed a drop in cognitive
function. Importantly, mice from all cohorts subjected to spon-
taneous exploration tasks exhibited normal motor function
and exploration.
Longer term studies (6 mo post-RT) were then conducted to
determine the persistence of the neuroprotective FLASH effect.
To analyze whether irradiated mice exhibited differences in be-
havioral characteristics indicative of anxiety and/or depression,
animals were subjected to an elevated plus maze (EPM) test and
a light-dark box (LDB) test to quantify anxiety behavior, along
with a forced swim test (FST) used to quantify depression be-
havior. Cohorts subjected to 10-Gy FLASH showed reduced
anxiety- and depression-like behavior compared with CONV-
irradiated mice (Fig. 1 D–F). The capability of FLASH to in-
definitely extend the onset and minimize the severity of persis-
tent radiation-induced mood disorders suggests that FLASH
does not trigger neurotoxic pathways.
The fact that anxiety and depression are not found after
FLASH-RT suggests a possible impact on extinction memory.
Therefore, mice were subjected to a rigorous protocol designed
to determine whether they could unlearn the association be-
tween a tone and mild foot shock (Fig. 1G). Data obtained
confirmed the nontoxic effects of FLASH-RT, as both control
and FLASH cohorts exhibited a progressive decline in freezing
behavior over extinction training. In contrast, CONV-irradiated
mice showed significantly higher freezing behavior (P < 0.05–
0.0001) (Fig. 1G). Animals subjected to the fear extinction test
24 h after the cessation of the extinction trials showed significant
overall group differences [F(2,25) = 7.27, P < 0.01] (Fig. 1G, g1).
Importantly, these differences persisted, as extinction between
controls and the FLASH cohort was identical, while CONV-
irradiated animals remained impaired. Cognitive data collected
over 6 mo following exposure provide compelling evidence for
the long-term neurocognitive sparing of FLASH-RT compared
with CONV irradiation.
Physicochemical Basis of the FLASH Effect: Minimizing Reactive
Oxygen Species Production. To rationalize the significant neuro-
protection afforded by FLASH, we postulated that delivering
radiation at ultra-high dose rates could reduce the yields of
reactive oxygen species (ROS) through a rapid depletion of
local oxygen concentration. To test this hypothesis in vivo, we
increased oxygen concentration in the brain via carbogen
breathing before and during 10-Gy whole-brain irradiation
(WBI) (Fig. 2A). Carbogen breathing, per se, had no impact on
the DI (mean ± SEM) of nonirradiated mice (58.34 ± 2.63 vs.
60.11 ± 2.28; P = 0.7990). No significant difference in DI was
observed in the carbogen- or air-breathing cohorts given
CONV irradiation (14.05 ± 5.61 vs. 8.95 ± 2.29; P = 0.2234).
Notwithstanding, a significant drop in DI was observed in the
carbogen-breathing mice irradiated with FLASH-RT compared
with air-breathing mice irradiated with the same irradiation
modality (28.53 ± 4.27 vs. 52.99 ± 1.99; P = 0.0079). These
striking results show that a simple doubling of the oxygen
concentration in the brain during irradiation was sufficient to
reverse the neurocognitive benefits of FLASH-RT. This ex-
periment supports our initial hypothesis that the beneficial ef-
fects of FLASH-RT are, in part, dependent on local oxygen
concentration and ROS production.
FLASH Irradiation Produces Less H2O2. To corroborate further our
underlying hypothesis, we specifically tested whether a given
isodose of FLASH would lead to lower levels of ROS compared
with CONV irradiation. Therefore, we quantified a critical end
product of water radiolysis, namely, H2O2, using a cell-free ra-
diochemical assay with AmplexRed after either irradiation mo-
dality (Fig. 2B). An aqueous oxygen concentration of 4% was
used as a mimetic of physiological oxygen tension. Interestingly,
and for all doses above 10 Gy, a significantly lower concentration
of H2O2 was observed in aqueous solutions subjected to FLASH
irradiation (P < 0.001) compared with CONV irradiation, sup-
porting our hypothesis that FLASH-RT reduces the production
of toxic ROS.
Additional studies analyzing the clonogenic survival of irra-
diated cells corroborated earlier work (20, 21) and showed that
FLASH doses of sufficient magnitude were radioprotective un-
der physiological oxygen conditions. Thus, while the lower dose
of 10 Gy was equitoxic (SI Appendix, Fig. S2 A and B), the higher
FLASH dose of 20 Gy (SI Appendix, Fig. S2B) was necessary to
demonstrate improved clonogenic survival compared with
CONV. Moving to a more physiological model involving zebra-
fish embryos, ROS scavenging using amifostine (SI Appendix,
Fig. S2C) and N-acetyl cysteine (NAC; SI Appendix, Fig. S2D)
was performed during FLASH and CONV irradiations. Body
length measurements 5 d postfertilization (dpf; size ± SD)
revealed that CONV irradiation of 4-h postfertilization (hpf)
embryos led to significant subsequent developmental alterations
compared with nonirradiated animals (1,255 ± 98.8 vs. 1,650 ±
25.3; P < 0.0001). FLASH-irradiated embryos showed signifi-
cantly fewer alterations in body length (1,349 ± 153 vs. 1,650 ±
25.3; P < 0.0001). Zebrafish embryos preincubated with either
antioxidant were protected from CONV radiation injury
(1,338 ± 111 vs. 1,255 ± 98.8; P = 0.018), whereas no further
protection was observed in the FLASH-RT groups (1,410 ±
27.0 vs. 1,349 ± 42.2; P = 0.2402). Moreover, even with the
amifostine treatment, reductions in body length of CONV-
irradiated embryos were still more extensive than in the FLASH
group without any treatment. The absence of biological impact
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Fig. 1. FLASH-RT minimizes radiation-induced neurocognitive complications. WT mice were tested for cognitive function using the NOR (A), OIP (B), and TO
(C) tasks. CONV irradiation (10 Gy) caused significant reductions in the DI on the NOR and TO tasks and similar trends on the OIP task compared with controls.
In each instance, FLASH-RT prevented radiation-induced cognitive deficits. Mean ± SEM (n = 8–12 mice per group). P values were derived from ANOVA and
the Bonferroni test. *P < 0.05, **P < 0.01 compared with the 10-Gy CONV group. At 6 mo post-RT, mice were subjected to the EPM test (D), LDB test (E), and
FST (F). Mice subjected to CONV irradiation spent significantly less time in the open arms of the EPM and exhibited significantly fewer transitions between the
light and dark regions of the LDB compared with controls. In contrast, FLASH cohorts showed a significant increase in the number of transitions between the
light and dark compartments compared with CONV cohorts. Mice exposed to CONV irradiation spent significantly more time floating compared with either
controls or the FLASH cohort. Mean ± SEM (n = 8–10 mice per group). P values were derived from ANOVA and the Bonferroni test. *P < 0.05, **P <
0.01 compared with the 10-Gy CONV group. (G) Exposure to either irradiation modality did not impair the acquisition of conditioned fear (three tone-shock
pairings). All mice showed a gradual decrease in freezing behavior over the 20 extinction trials (tone only); however, the time spent freezing was significantly
greater for the mice irradiated with CONV compared with controls or the FLASH cohort. (g1) Control and FLASH mice successfully abolished fear memory
compared with the CONV group. Mean ± SEM (n = 8–10 mice per group). P values were derived from two-way repeated ANOVA followed by the Bonferroni
test: *P < 0.05, **P < 0.01, ***P < 0.001.
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in the presence of the potent scavengers following FLASH-RT
corroborates our hypothesis that FLASH-RT leads to a lower
production of ROS, with concomitant reductions in radiation-
induced normal tissue damage.
Attenuation of Neuroinflammation by FLASH-RT. Evidence pointing
to the mechanistic role of lower ROS levels in mediating the
FLASH effect suggested that downstream biological pathways
known to be responsive to oxidative injury might be involved.
Therefore, given the causal relationship between radiation-
induced oxidative stress and inflammation, studies were initiated
to investigate the impact of FLASH-RT on neuroinflammatory
processes. To start, the expression of GFAP in the striatum of
nonirradiated and irradiated mice was quantified by immuno-
fluorescence to assess the occurrence of radiation-induced
astrogliosis. No difference between the groups was observed at
acute (3-d) times post-RT. However, at 14 d and 2 mo post-RT,
the 10-Gy CONV–irradiated group exhibited a significant 3.6-
fold and 2.6-fold increase in GFAP immunoreactivity (P =
0.0077 and P = 0.0034, respectively; Fig. 3 A and B). At 14 d,
GFAP staining was located around CD31+ cells, with the pres-
ence of numerous astrocytes in close proximity to blood vessels
(Fig. 3A). At 2 mo, GFAP staining was consistent with the oc-
currence of radiation-induced scar astrogliosis (Fig. 3B). In
contrast, the 10-Gy FLASH–irradiated group showed no change
in GFAP levels at 14 d and 2 mo post-RT, when cellular staining
and localization were similar to those found in the nonirradiated
controls (Fig. 3 A and B). These data indicate that FLASH-RT
did not induce subacute activation of astrogliosis or delayed
radiation-induced scar astrogliosis, evidence demonstrating the
long-lasting benefits of FLASH-RT that might underlie the
preservation of cognitive function.
To ascertain the impact of each irradiation modality on
microglia, we quantified the number of IBA-1+ (resting or total)
and CD68+ (activated) microglia in the hippocampus at 1 mo and
6 mo after exposure. While resting microglia levels were un-
responsive to radiation dose rate (SI Appendix, Fig. S3), the re-
sponse of activated microglia was found to be significantly
different in the hippocampus 1 mo following each irradiation
modality (Fig. 3C). Consistent with past results, CONV irradia-
tion caused a significant increase in the number of CD68+ cells
compared with controls (P < 0.0001) and, importantly, FLASH
irradiation reduced significantly (P < 0.0001) the yield of activated
microglia to control levels (Fig. 3D). Remarkably, similar pro-
tective effects were found to persist 6 mo following irradiation (Fig.
3D). These data suggest that one mechanism by which FLASH-
RT does not cause neurocognitive decline is by reducing
radiation-induced ROS, that prevents the early activation of
microglia, thereby limiting their transition to a chronically
activated state.
Preservation of Host Neuronal Structure and Synaptic Protein Levels
by FLASH-RT. Microglia have been shown to actively reshape the
synaptic landscape, by pruning dendritic arbors in response to
various stressors and microenvironmental cues. Irradiation has
also been shown to elicit significant structural plasticity in the
irradiated brain, which is able to compromise the morphology of
multiple mature neuronal subtypes throughout various regions of
the brain (22). Therefore, to determine whether FLASH-RT had
a differential impact on neuronal morphology compared with
CONV irradiation, mice were analyzed for structural changes in
hippocampal granule cell neurons 1 mo and 6 mo after exposure.
Reconstructed images revealed a significant loss of dendritic
complexity, coupled with a reduction in the number of dendritic
spines in the CONV cohort compared with controls 1 mo after
exposure, an effect that was not evident in the FLASH-irradiated
group (Fig. 4 A and B). Quantification and analyses of dendritic
parameters indicated that FLASH-irradiated cohorts did not
exhibit the same level of dendritic alterations in the area (P <
0.01), length (P < 0.05), and branches (P < 0.01) compared with
the CONV cohorts (Fig. 4C). Further analyses of dendritic
spines revealed that compared with CONV cohorts, FLASH-
irradiated animals had significantly higher numbers of den-
dritic spines (P < 0.05), elevated spine density (P < 0.0001), and
higher spine volume (P < 0.01) (Fig. 4D).
Importantly, long-term analyses were conducted 6 mo fol-
lowing exposure to determine the persistence of any structural
changes caused by either irradiation modality. Quantification
Fig. 2. FLASH effect depends on tissue partial pressure of oxygen (pO2) and reduced ROS production. WT mice anesthetized under normoxia or carbogen
breathing (O2 groups) were subjected to the NOR test 2 mo postirradiation. (A) Increase in normal brain pO2 caused by carbogen breathing before and during
the irradiation delivery reversed the neurocognitive sparing induced by FLASH found under normoxia to levels observed after CONV irradiation. Data are
expressed as mean DI ± SD (n = 5–16 animals per group). P values were derived from the Mann–Whitney U test: ***P < 0.001 compared with the control
nonirradiated group and +P < 0.05; ++P < 0.01 compared with the control + O2 group. ns, not significant. (B) Water equilibrated at a 4% O2 tension was
irradiated with CONV and FLASH-RT, and H2O2 production was quantified by Amplex Red measurements. FLASH irradiation produces significantly less H2O2
than CONV at equivalent doses. Mean ± SD P values were derived from Mann–Whitney U test: ***P < 0.001.
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and analyses of dendritic parameters at this protracted end point
revealed that CONV irradiation caused persistent and significant
reductions in dendritic area (P < 0.0001), length (P < 0.0001), and
branches (P < 0.01) compared with controls. These effects were
not found in the FLASH-irradiated cohorts, and compared with
CONV cohorts, FLASH irradiation spared significantly dendritic
area (P < 0.0001), length (P < 0.0001), and branches (Fig. 4E).
Additional analyses of dendritic spine parameters revealed the
persistent benefits of FLASH irradiation. At this chronic post-
irradiation time point, cohorts subjected to CONV irradiation
exhibited significant reductions in dendritic spine density (P <
0.001) and volume (P < 0.0005), with trends for reduced spine
numbers (Fig. 4F). While positive trends were found for increased
spine numbers after FLASH-RT, multiple comparison analyses
indicated that FLASH cohorts exhibited significant increases in
spine density (P < 0.001) and volume (P < 0.005) compared with
CONV cohorts (Fig. 4F). Morphologic data collected over a 6-mo
interval point to the neuroprotective properties of FLASH-RT
and provide conclusive evidence that FLASH irradiation does
not cause the short- or long-term structural deterioration of ma-
ture neuronal morphology that is likely to have an adverse func-
tional impact on cognition.
To investigate further the mechanisms by which FLASH-RT
might differentially impact the synaptic landscape in the brain
compared with CONV irradiation, we analyzed postsynaptic
density protein 95 (PSD-95). Past work has shown CONV irra-
diation to alter the expression of PSD-95 foci in certain hippo-
campal and cortical regions of the brain (12, 22), and the current
study sought to determine the response of this critical synaptic
protein to FLASH irradiation. Interestingly, data indicate that
FLASH-RT maintained a synaptic landscape more similar to a
nonirradiated brain (SI Appendix, Fig. S4).
Discussion
The relative absence of normal tissue toxicity following FLASH
irradiation, also known as the “FLASH effect,” has caught the
field by surprise, representing a rather unexpected outcome.
Data presented provide compelling evidence that the FLASH
effect is, at least in part, mediated by a lower production of ROS.
Thus, FLASH may be able to disrupt and bypass ROS-mediated
pathogenic cascades that normally lead to neurocognitive com-
plications and associated pathology typically found after CONV
irradiation of the brain. The absence of normal tissue toxicity
observed after FLASH irradiation and reported here corrobo-
rates recent and older work from our laboratories and others on
the normal brain, lung, skin, and gut (18, 19, 23, 24) and, as
recently reviewed (25), point to the general applicability of
FLASH irradiation to avoid normal tissue injury. Normal tissue
sparing reported here is especially relevant in the context of
current treatment regimens for adult and pediatric brain tumors
that elicit significant toxicities that negatively impact patient care
and quality of life (5, 26). Since this unfortunate reality remains
an unmet medical need, we used tumor-free animals to in-
vestigate the short- and long-term neuroprotective mechanisms
of FLASH-RT in the absence of confounding disease.
The comprehensive array of behavioral testing provided
compelling evidence that unlike CONV irradiation (27, 28),
FLASH-RT did not cause hippocampal- and/or cortical-based
deficits in learning and memory and did not result in behaviors
characteristic of anxiety and depression. To investigate the po-
tential neuroprotective mechanisms, we explored the role of
oxygen and ROS using a series of different model systems and
approaches. First, oxygen supplementation (doubling of partial
pressure of oxygen) via carbogen breathing (29) in mice was
found to reverse the beneficial effects of FLASH on cognition.
Follow-up radiochemical studies substantiated that FLASH re-
duced hydrogen peroxide levels, and in vitro studies found that
FLASH could improve clonogenic survival at doses sufficient to
adequately deplete oxygen. Scavenging studies implementing
millimolar concentrations of antioxidants were then shown to
have little to no effect on FLASH-irradiated zebrafish embryos.
The foregoing data support the ROS dependence of the FLASH
Fig. 3. FLASH-RT reduces indications of neuroinflammation. Micrographs show
GFAP+ astrocytes (red) in the vicinity (arrows) of CD31+ endothelial cells (green).
(Scale bars: 100 μm.) (A) CONV irradiation (IR) leads to amarked rise in GFAP+ cells,
indicating an increase in reactive gliosis. FLASH did not elicit such increased levels
of reactive gliosis andwas comparable to controls. (B) Quantification of these data
at 2 wk and 2 mo post-IR reveals qualitatively similar yet significant effects. For
each post-IR time, CONV IR increased reactive gliosis significantly, whereas FLASH-
RT did not, being statistically similar to controls. Mean ± SD (n = 5 animals per
group), P values were derived from the nonparametric Mann–Whitney U test:
*P < 0.05, **P < 0.01 compared with the 10-Gy CONV group. (C) Micrographs
from the hippocampal dentate hilus (DH) and granule cell layer (GCL) show CD68+
activated microglia (red, arrows) against granule cell neurons (blue). (Scale bars:
40 μm.) (D) There was a marked increase in activated microglia (CD68+) at both
1 and 6 mo following CONV IR compared with controls. FLASH-RT prevented the
increase in activatedmicroglia andwas statistically indistinguishable from controls.
Mean ± SEM (n = 4 animals per group). P values were derived from ANOVA and
the Bonferroni test: **P < 0.01 compared with the 10-Gy CONV group.
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effect, where its cytotoxicity seems dependent primarily on the
direct effect. This distinguishes the FLASH effect from CONV
irradiation, where both the indirect and direct effects of ionizing
radiation govern radiation sensitivity (30).
Our observations are consistent with previous studies showing
that bacteria at a given oxygen tension were less sensitive to
ultra-high versus CONV irradiation (31, 32). Related results
were also obtained with mammalian clonogenic survival (21, 33,
34). Each of these studies concluded that irradiation at an ultra-
high dose rate could induce a protective effect via transient de-
pletion of oxygen, but none ever demonstrated the effect in vivo.
Although direct oxygen measurement during FLASH irradiation
is not feasible in vivo due to the very short time of irradiation
(microsecond range), we demonstrate a consistent decrease in
ROS production in various systems ranging from a cell-free
system to in vitro and complex in vivo models (mouse and
zebrafish). We posit that the “instantaneous” depletion of oxy-
gen, and subsequent low level of ROS triggered by FLASH,
constitutes one of the primary mechanisms able to modify the
entire biological cascade driving normal tissue toxicity.
To support further the role of oxidative stress in the FLASH
effect, we investigated the response of oxidative-sensitive path-
ways in the brain. We explored whether FLASH irradiation
might exploit alternative damage surveillance pathways in nor-
mal tissue, possibly operating under damage detection thresh-
olds. Interestingly, reactive gliosis and astrogliosis, known to
perpetuate neuroinflammatory cascades and vasculature damage
and to disrupt CNS functionality in the conventionally irradiated
brain (35, 36), were virtually nonexistent in the FLASH-irradiated
brain. The conspicuous absence of short- or long-term astrocytic
and/or microglial activation was also coincident with a preserva-
tion of mature neuronal structure. Of particular significance was
the structural preservation of neuronal morphology found 6 mo
after FLASH, which included a stabilization of the critical synaptic
protein PSD-95 (37, 38). Interestingly, improved cognition (39),
reductions in neuroinflammation (40), and protection of den-
dritic complexity (9) after irradiation have only been docu-
mented following stem cell and stem cell-derived exosome
transplantation. While these interventions likely operate through
trophic support mechanisms, FLASH-RT will most likely oper-
ate through completely different mechanisms able to preserve
neurotransmission.
Recent and current data make a compelling case for the
FLASH technology being at the cusp of changing radiotherapeutic
protocols worldwide. Noteworthy too is the surprising realization
that FLASH achieves such marked and persistent normal tissue
sparing while transpiring within microseconds. Interventions
within this rapid timeframe are simply not obtainable from the
vast majority of efforts focused on biological and pharmacolog-
ical strategies, typically able to intervene on processes operating
on relative timescales six orders of magnitude slower (Fig. 5A).
This highlights why this technology stands to change the land-
scape of radiotherapy, in addition to its obvious capability to
freeze organ/tumor motion. Importantly, normal tissues and tu-
mors exhibit differential responses to FLASH (18, 41, 42). This
can be rationalized, in part, since normal tissue is already maxi-
mally sensitized to ionizing radiation under normoxic conditions
(oxygen levels of ∼4–6%) and only becomes meaningfully resistant
Fig. 4. FLASH-RT preserves host neuronal morphology 2 and 6 mo post-
irradiation (post-IR). (A) Neuronal dendrites (green) along with major branch
points (blue) are shown in each IR cohort. The neuronal arborization is re-
duced 1 mo post-IR by CONV IR (10-Gy CONV) compared with controls, an
effect not apparent after FLASH. (B) Higher magnification view of dendritic
spines (red) against the dendritic tree (green). Dendritic spine numbers are
reduced following CONV IR compared with controls, an effect again not
evident in the FLASH-irradiated brain. (Scale bars: A, 20 μm; B, 5 μm.) (C)
Reductions in dendritic area, length, and branching following CONV IR
compared with controls were evident, effects that were all significantly
preserved in the FLASH-irradiated brain. (D) Similar findings were evident
following quantification of dendritic spines, where reductions in spine
numbers, density, and volume were found after CONV IR compared with
controls. (E) Analyses of granule cell neurons at 6 mo post-IR reveals per-
sistent reductions in dendritic area, length, and branching following CONV
IR compared with controls, effects that were all ameliorated significantly in
the FLASH-irradiated brain. (F) Similar findings were again evident following
quantification of dendritic spines, where reductions in spine numbers,
density, and volume were found after CONV IR compared with controls.
With the exception of spine numbers, FLASH again preserved dendritic spine
parameters significantly. Data are expressed as mean ± SEM (n = 4 animals
per group). P values were derived from one-way ANOVA followed by Bon-
ferroni multiple comparison post hoc analysis: *P < 0.05, **P < 0.01, ***P <
0.001.
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under conditions where oxygen levels approach ≤1.5%, whereas
tumors, including GBM, contain regions of hypoxia. Lastly, we
provide mechanistic evidence that the benefits of FLASH-RT in-
volve reduced production of toxic ROS (Fig. 5B). The resultant
increase in normal tissue tolerance affords a significant potential for
dose escalation, while avoiding severe late effects and toxicities
associated with previous chemical modifiers and/or altered frac-
tionation protocols. Further experimentation is clearly needed to
fully characterize the biological parameters altered after tissue
exposure to FLASH-RT, thereby opening an area of research.
However, based on current results, rapid implementation of this
promising cancer treatment seems just a matter of time once this
technology becomes widely available.
Material and Methods
Irradiation Devices. Irradiation was performed using a prototype 6MeV
electron beam linear accelerator (LINAC) of type Oriatron 6e (eRT6; PMB-
Alcen), available at Lausanne University Hospital and described previously
(43). Physical dosimetry has been extensively described and published to
ensure reproducible and reliable biological studies (19, 43–45). This LINAC is
able to produce pulsed electron beams at a mean dose rate ranging from 0.1
Gy·s−1 (i.e., comparable to conventional dose rates used in RT) up to 1,000
Gy·s−1, corresponding to a dose, in each electron pulse, ranging from 0.01 up
to 10 Gy. All FLASH irradiations were performed at a mean dose rate above
100 Gy·s−1 and at a dose rate within the pulse above 1.8.106 Gy·s−1. The beam
parameters used throughout this study are included in SI Appendix, Tables S1–
S4. The irradiation settings corresponding to the prescription dose for mouse
irradiations were determined by surface dose measurements on a 30 × 30-cm2
solid water slab positioned behind a 1.7-cm-diameter aperture of a graphite
applicator (13.0 × 13.0 × 2.5 cm3), as previously described (19). The irradiation
settings corresponding to the prescription dose for in vitro and zebrafish
embryo irradiations were performed in a T41023 water tank (PTW-Freiburg
GmbH) with an Advanced Markus ionization chamber (PTW-Freiburg GmbH)
corrected for the drop in ion collection efficiency with increased dose per
pulse (46).
Animal Experiments. Animal experiments were approved by the Swiss (Vaud
state approval: VD2920 and 3241) and University of California, Irvine (In-
stitutional Animal Care and Use Committee) ethics committees for animal
experimentation and performed within institutional guidelines.
WBIs. Female C57Bl6/J mice (n = 5–16 animals per group) were purchased
from Charles River Laboratories at the age of 8 wk. Tumor-free transgenic
mice [n = 10–12 animals per group; strain Tg(Thy1-eGFP) MJrsJ, stock no.
007788; The Jackson Laboratory] were bred at the University of California,
Irvine animal facility. WBIs were performed under isoflurane anesthesia.
The mouse head was positioned behind and in contact with the aperture
of the 1.7-cm-diameter graphite applicator to irradiate the whole en-
cephalon region, while limiting the dose to the eyes, the mouth, and the
rest of the body. For irradiations in hyperoxic conditions, mice were
anesthetized with isoflurane and carbogen (95% O2, 5% CO2) for 20 min,
including the irradiation time.
Cognitive Testing. To determine the effects of CONV and FLASH irradiations
on cognitive function, mice were subjected to behavioral testing 1 and 6 mo
after irradiation. Early testing (1 mo) was conducted over 2 wk and included
three open-field, spontaneous exploration tasks following our previously
described protocols (10, 19, 35, 47). Data analysis was conducted in-
dependently and blindly, and is presented as the average of all trials scored
for each task. Tumor-free Thy1-EGFP mice were subjected to an extensive
neurocognitive test battery to eliminate any confounding effects of disease.
These animals were first administered the NOR task, followed by the OIP
task and, lastly, the TO task.
The NOR task involved a sequence of habituation (no objects), familiar-
ization (two distinct objects), and, lastly, a test phase in which one of the prior
objects is switched with a new one. Animals have a tendency to explore the
novel object, and successful performance on this task is reliant on intact
perirhinal cortex function (48, 49).
For the OIP task, animals were habituated and then familiarized with four
different objects at discrete locations. Following familiarization, the location
of two objects is switched and animals are reintroduced to the arena for the
test phase and their ability to discriminate the novel object locations. Per-
formance on the OIP task is dependent on intact hippocampal function in
addition to the prefrontal and perirhinal cortices (48, 49).
For the TO task, animals were familiarized with two sets of objects 4 h
apart. In this instance, mice with functional connectivity between the
hippocampus, medial prefrontal cortex (mPFC), and perirhinal cortex show
a preference for exploring the prior object, rather than the more recent
object (48, 49).
Time spent exploring both familiar and novel objects was counted
when the nose of the mouse was within 1 cm and pointed in the direction
of the object. Mice did not show object climbing or neophobic behavior.
NOR, OIP, and TO data are presented as a DI and calculated as ([Novel
location exploration time/Total exploration time] − [Familiar location
exploration time/Total exploration time]). A positive index indicates that
a mouse spent more time exploring novelty (i.e., switched objects or
locations), while a negative score indicates little or no preference for
exploring novelty.
Longer term (6mo) assessments of behavior necessitated the use of tumor-
free mice and were designed to assess potential radiation-induced changes in
anxiety, depression, and extinction (5, 6, 8, 50–53). The EPM, LDB, and FST
tests provide indirect measures of anxiety- and depression-like behavior,
Fig. 5. Differential physicochemical events distinguish FLASH from CONV irradiation. For the delivery of a similar dose, FLASH irradiation is 1,000-fold more
rapid than CONV irradiation. (A) While CONV irradiation transpires during ongoing chemical and biological responses, FLASH does not interact with these
early radiation reactions. (B) FLASH induces the rapid depletion of oxygen and a transient local hypoxia, thereby reducing ROS levels and normal brain toxicity
compared with CONV irradiation.
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respectively (10, 47). The former two tasks measure an animal’s confidence
for exploring the open rather than closed arms of a maze or the tendency to
move between dark and light areas, while the latter task provides a measure
of despair, as animals suffering from depression tend to float more often.
These tasks are quantified by calculating the amount of time spent in the
open versus closed arms of the EPM, the number of transitions between light
and dark regions of the LDB, or the amount of time floating versus swim-
ming during the FST, behaviors that can each be linked to the amygdala
(among other regions).
Fear extinction follows a modified fear conditioning protocol (54) in which
repeated trials dissociating the tone-shock pairing can be used to measure the
rate of reduced freezing or fear extinction. Deficits in this behavior have been
linked to the infralimbic region of the mPFC and require active learning,
thereby providing a measure of cognitive flexibility. Briefly, mice received
three conditioning trials (tone-foot shock pairings) to establish fear. Mice were
placed in a conditioning chamber with Plexiglas walls and a metal grid bot-
tom. They were left to acclimate for 2 min and were given the tone followed
by a mild foot shock (1 s, 0.7-mA constant current). Freezing was used to
measure the conditional fear response during the fear conditioning phase,
extinction training phase, and testing phase. At 24 h following conditioning,
animals were trained to “unlearn” the association by repeatedly playing
the tone without the shock. Mice were given a total of 12 extinction trials
(tone alone) in 3 d (3 × 4 trials) to test their ability to extinguish condi-
tioned fear in the same context. The inability to unlearn the association
reinforced during conditioning with the tone-foot shock pairing during
the extinction and test phases indicates impairment in extinction memory.
Deficits in this behavior have been linked to the infralimbic region of the
mPFC and require active unlearning, thereby providing another measure
of cognitive flexibility, or the ability to adapt to a changing environment
(10, 47, 55, 56).
H2O2 Production Measurements (Amplex Red). H2O2 production measure-
ments were performed using Amplex Red staining. Ultra-pure MilliQ water
(6.9 < pH <7.1; 21–22 °C) was equilibrated in a hypoxia hood for 24 h at
4% O2. Water was irradiated in airtight Eppendorf polypropylene tubes at
0, 10, 20, 30, 40, 50, 60, 70, or 80 Gy at FLASH or CONV in a water tank.
AmplexRed was added to the irradiated water (vol/vol) exactly 195 s after
the beginning of irradiation at a final concentration of 16.67 μM (pre-
viously defined as optimal) and incubated for 90 min protected from light.
H2O2 solutions from 0.007 to 10 μM were used as standards. Fluorescence
quantification was performed using a plate reader 90 min postirradiation
(excitation: 530 nm, emission: 590 nm). Measurements were realized
in triplicate.
Clonogenic Assays. The isolation and characterization of the murine glio-
blastoma H454 cells have been described (57). Cells were cultured in DMEM +
10% FBS (Thermo Fisher Scientific) at 37 °C and under different dioxygen
concentrations: 4% or 21%. On the day of irradiation, cells were harvested
with trypsin + 0.25% EDTA (Thermo Fisher Scientific), counted, and placed
in airtight Eppendorf tubes for cell suspension irradiations. Tubes were ir-
radiated in a water tank at 0, 10, or 20 Gy at FLASH or CONV. Cells were
then plated at a concentration of 1,000–100,000 cells in six-well plates or
Petri dishes and incubated at 37 °C in 5% CO2, 21% O2. At 7 d post-
irradiation, colonies were fixed and stained using Crystal Violet (Sigma).
Colonies over 50 cells were counted, and plating efficiency and survival
fractions were determined.
Oxidative Stress Measurement in Zebrafish. For in vivo oxidative stress studies,
wild-type (WT) zebrafish were bred in our fish facility (Lausanne University
Hospital). All in vivo experiments on zebrafish were performed on embryos
under 5 dpf. Fertilized WT zebrafish eggs were incubated at 28 °C until
5 dpf. Anesthesia was performed with 168 mg/L tricaine, and 10–20 embryos
were transferred in 2-mL Eppendorf tubes. Water + tricaine was then re-
moved and replaced by pure H2O + 60 mg/L ocean salt. For antioxidant
treatments on WT animals, NAC (5 mM, pH 7.5; Sigma) or amifostine (4 mM;
Sigma–Aldrich) was added to the water 1 h before irradiation. Irradiation
was performed 4 hpf at 8-Gy FLASH and CONV in 2-mL Eppendorf tubes
placed in a water tank as described above. Embryos were fixed 5 dpf with a
solution of paraformaldehyde (4% final concentration) before microscopic
analysis (Evos XL Core Cell Imaging System; Thermo Fisher Scientific). Fish
length was measured using ImageJ 1.X. software.
Immunohistochemistry, Confocal Microscopy, and Quantification. At select
times postirradiation, animals were prepared for immunohistochemistry as
described previously (9). Brains were cryoprotected (30% sucrose) and sec-
tioned coronally (30–35 μm thick) using a cryostat (Leica Microsystems). For
astrogliosis, GFAP and CD31 expression was assessed in the striatum of
control and irradiated mice. Floating brain sections were incubated with
anti-GFAP (1:500; clone GA5; MAB360) and anti-CD31 (1:150, 553370; BD
Biosciences) primary antibodies. Alexa Fluor 568-labeled goat anti-mouse
(1:200, A21124; Thermo Fisher Scientific) and Alexa 488-labeled donkey
anti-rat (1:200, A11070; Thermo Fisher Scientific) secondary antibodies were
used. Two to four sections per animal were mounted on microscope slides
with Vectashield + DAPI (H-1500; Vector Laboratories). Image acquisition
was performed using an upright Zeiss Axiovison microscope. GFAP expres-
sion area was quantified using ImageJ software.
For the assessment of microglia, the following primary and secondary
antibodies were used: rabbit anti–IBA-1 (1:500; Wako), rat anti-mouse CD68
(1:500; AbD Serotec), donkey anti-rabbit or anti-mouse conjugated with
Alexa Fluor 488 or 594 (Life Technologies/Invitrogen), and DAPI nuclear
counterstain (Sigma–Aldrich). Representative sections (three to four sections
per animal, four to six animals per group) through the middle of the hip-
pocampus were selected, and immunofluorescence staining followed pro-
cedures described in detail previously (16, 58). Immunofluorescent sections
were imaged using a Nikon Eclipse Ti C2 microscope to obtain 20–30 Z-stacks
(1,024 × 1,024 pixels, 1 μm each) using 10× and 60× PlanApo oil-immersion
lens (Nikon). For quantification of IBA-1+ and CD68+ cells, 3D deconvolution
and reconstruction were carried out using the AutoQuantX3 algorithm
(MediaCybernetics). Quantification was facilitated using the Imaris spot tool
(v8.0; Bit Plane, Inc.).
The assessment of PSD-95 foci has been described previously (12, 22).
Briefly, serial 30-μm-thick sections (three per animal) from the anterior-
to-posterior hippocampus were selected, and three different fields in
each section were imaged from the dentate gyrus. Images were collected
using a Nikon Eclipse TE 2000-Umicroscope with 0.5-μm-interval high-resolution
Z-stacks (1,024 × 1,024 pixels). Analysis of PSD-95 was performed using the
Imaris spot tool, and puncta satisfying predefined criteria (verified visually for
accuracy) were converted to spots for quantification under preset parameters
kept constant throughout subsequent analyses.
Morphometric Assessments of Neurons. Details regarding the reconstruction
of neurons and the morphologic classification of spines have been de-
scribed (12, 22). For dendritic analyses, 100-μm-thick hippocampal sections
were prepared for confocal imaging. Three sections per animal were used
to generate Z-stacks from four animals using a Nikon Eclipse TE 2000-U
microscope. Images comprising each Z-stack (1,024 × 1,024 pixels) were
acquired (60×) over the entire dendrite tree at 0.5-μm increments.
Quantification of dendritic parameters was derived from Z-stacks recon-
structed in three dimensions from deconvoluted images using the
AutoQuantX3 algorithm. Deconvoluted 3D reconstructions yielded high
spatial resolution images for detailed dendritic tracing and spine classifi-
cation using the Imaris software suite (Bitplane, Inc.) as described pre-
viously (12, 22). For spines to be included in our analyses, a maximum spine
length and minimum spine end diameter were set at 2.5 nm and 0.4 nm, re-
spectively. Parameters of neuronal structure that were identified and quanti-
fied through image reconstruction and deconvolution using the Imaris
software suite included the cell body, dendritic and axonal length, branching
and branch points, dendritic complexity, spines, and boutons.
Statistics. Statistical analyses were carried out using GraphPad Prism (v6)
software. One-way ANOVA was used to assess significance between control
and irradiated groups, and when overall group effects were found to be
statistically significant, a Bonferroni multiple comparisons test was used to
compare the control and FLASH groups against the CONV cohort. In addition,
the unpaired nonparametric Mann–Whitney U test or unpaired t test after
Gaussian distribution assessment by the Shapiro–Wilk normality test were
used. Results were expressed as mean values ± SD or mean values ± SEM, and
all analyses considered a value of P ≤ 0.05 to be statistically significant.
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Figure S1: Radiation-induced neurocognitive assessments after dose escalation 
with FLASH-RT 
WT mice were tested using the novel object recognition (NOR) task. Conventional-
dose-rate irradiation at 10 Gy caused significant reductions in DI whereas 10 and 12 Gy 
doses administered by FLASH prevented radiation-induced cognitive deficits. 
Interestingly, at the higher dose of 14 Gy, the benefits of FLASH were lost, as DI values 
were similar to that found after conventional dose-rate irradiation. Mean ±SEM (N=5-13 
mice/group), P values derived from unpaired t-tests performed after Gaussian 
distribution assessment with Shapiro test. **P<0.01; ***P<0.001, compared to the 10 Gy 
CONV group. 
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Figure S2: The FLASH effect occurs at high dose and induces oxidative stress  
H454 clonogenic survival was quantified after the delivery of 10 (A) or 20 Gy (B) at 
CONV or FLASH-RT and under atmospheric (21%) or physiologic (4%) oxic conditions. 
Clonogenic survival of H454 cells is found to be higher after the delivery of 20 Gy with 
FLASH-RT and in physiologic oxic conditions (B). Mean ± SD. P values derived from 
Mann-Whitney’s-test: ***P<0.001 (N=3 assays). Radiation-induced alterations of 
zebrafish morphology were assessed by body length measurements following 8 Gy in 
the presence of antioxidants (4mM Amifostine (C) or 5mM NAC (D). FLASH induced 
fewer morphological alterations than all other irradiated groups. In contrast to the 
groups irradiated with conventional irradiation, the treatment with both antioxidants did 
not ameliorate the radiation-induced toxicity mediated with FLASH. Mean ± SD. P 
values derived from Mann-Whitney’s-test: *P<0.05; ** P<0.01; ***P<0.001 (N=9-19 
embryos/group). 
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Figure S3: FLASH-RT has a minimal impact on resting microglia. 
Immunofluorescence staining and laser scanning confocal microcopy was performed on 
brain sections selected from each irradiated cohort. Representative high-resolution 
(60×) confocal micrographs from the hippocampal dentate hilus (DH) and granule cell 
layer (GCL) show IBA-1+ microglial cell bodies (red) against the background of granule 
cell neurons (blue) for each of the experimental cohorts (A). Quantification of IBA-1+ 
microglia show little effect at 1 month, but a reduction at 6 months after conventional 
dose-rate irradiation (B). For resting microglia, FLASH cohort was statistically 
indistinguishable from controls at each of these time points (B). Data are presented as 
mean ±SEM (N=4animals/group. P values derived from ANOVA and Bonferroni’s 
multiple comparisons test. *P< 0.05; **P< 0.01, compared to the 10 Gy CONV group. 
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Figure S4: FLASH-RT does not perturb PSD-95 levels compared to conventional 
dose-rate irradiation.  
Representative fluorescence micrographs showing PSD-95 puncta (red) against the 
soma (blue) of granule cell neurons following each irradiation modality (A). Quantitative 
analyses of fluorescent PSD-95 foci show that exposure to conventional dose-rate 
reduces PSD-95 levels in the dentate gyrus (DG) at both 1 (B) and 6 months (D) 
following exposure compared to controls, an effect not found in the FLASH irradiated 
brain. Analysis of CA1 pyramidal cell neurons reveals different trends in PSD-95 levels 
after irradiation, but after 1 month (C) or 6 month (E), the FLASH irradiated brain was 
similar to controls, and did not show the types of changes evident after conventional 
dose-rate irradiation. Data are expressed as the mean ± SEM. *P< 0.05; **P< 0.01; 
Two-way repeated ANOVA followed by Bonferroni post-hoc test. 
 
 6 
 
Supplementary Table 1 
 
Normal tissue toxicity  
+/-carbogen 
(Fig. 1-4 and Fig. S1-S3) 
 
Beam parameters 
Mode Prescribed Dose (Gy) 
Frequency 
(Hz) 
SSD 
(mm) 
Pulse 
width 
(µs) 
Number of 
pulses 
Treatment time 
(s) 
CONV 10 10 612-800 1.0 639-1180 63.8-117.9 
FLASH 
10 100 350 1.8 1 1.8·10-6 
12 100 320 1.8 1 1.8·10-6 
14 100 297 1.8 1 1.8·10-6 
 
 
Supplementary Table 2 
 
Pure water 
(Fig. 5A) Beam parameters 
Mode Prescribed Dose (Gy) 
Frequency 
(Hz) 
SSD 
(mm) 
Pulse 
width (µs) 
Number of 
pulses 
Treatment time 
(s) 
CONV 
10 
10 400 1.0 
350 349.9 
20 696 69.5 
30 1047 104.6 
40 1390 138.8 
50 1730 172.9 
60 2075 207.4 
70 2440 243.9 
80 2800 279.9 
FLASH 
10 
100 460 
1.75 2 0.01 
20 1.8 4 0.03 
30 1.84 6 0.05 
40 1.87 8 0.07 
50 1.89 10 0.09 
60 1.9 12 0.11 
70 1.87 14 0.13 
80 1.87 16 0.15 
 
 
 
 7 
Supplementary Table 3 
 
Clonogenic cell survival 
(Fig. 5B) 
 Beam parameters 
Mode Prescribed Dose (Gy) 
Frequency 
(Hz) 
SSD 
(mm) 
Pulse 
width (µs) 
Number of 
pulses 
Treatment time 
(s) 
CONV 10 10 400 1.0 505 50.4 20 1000 99.9 
FLASH 10 100 335 1.98 2 0.01 20 388 1.48 3 0.02 
 
Supplementary Table 4 
 
Fish eggs; +/- NAC             
+/- Amifostine 
(Fig. 5C) 
Beam parameters 
Mode Prescribed Dose (Gy) 
Frequency 
(Hz) 
SSD 
(mm) 
Pulse width 
(µs) 
Number of 
pulses Treatment time (s) 
CONV 8 10 808 1.0 1262 126.1 
FLASH 8 200 350 1.49 1 1.49·10-6 
 
 
 
